Advertisement

Effect of Prophylactic Management of Hemophilia on Bleeding Episodes

  • Suman Roy
  • Arun kumar De
Original Article

Abstract

Hemophilia A (factor VIII deficiency) and hemophilia B (factor IX deficiency) are the most common and serious congenital coagulation factor deficiencies with repeated hemarthroses leading to development of target joints. Continuous prophylaxis is regular infusion of factor concentrates at fixed dose at regular interval to prevent hemorrhages. The study was designed to assess the outcome of continuous prophylaxis in hemophilia on bleeding episodes. It was conducted from November, 2017 to April, 2018 in the Paediatrics Department of Midnapore Medical College, Paschim Medinipur, West Bengal on 33 boys from 4 to 18 years of age suffering from Hemophilia with frequent bleeding episodes. Prior to starting continuous prophylaxis all the patients’ target joint(s) were assessed based on Gilbert Score and bleeding episodes in the last 6 months were assessed based on Annualized Bleeding Rate and ISTH-BAT Score. All the children were provided prophylaxis therapy with plasma derived Factor concentrate twice per week at a dose of 20 + − 2 IU/Kg. All bleeding episodes of the children during prophylaxis were recorded. Bleeding episodes showed significant improvement only in children who could sufficiently adhere to continuous prophylactic therapy. Continuous prophylaxis reduces bleeding episodes in Hemophilia in twice weekly protocol provided the patients sufficiently adhere to continuous prophylaxis regimen.

Keywords

Hemarthrosis Gilbert score ISTH-BAT score Prophylaxis 

Notes

Compliance with Ethical Standards

Ethical Approval

All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. The study was explained to all participants and their parents. Informed consent was taken from all the individual children as well as their parents included in the study.

References

  1. 1.
    Scott JP, Flood VH (2016) Hereditory clotting factor deficiencies. In: Kliegman R, Stanton B, St. Geme JW, Schor NF, Behrman RE (eds) Nelson textbook of pediatrics, 20th edn. Elsevier, Phialdelphia, p 2348Google Scholar
  2. 2.
    Jayandharan GR, Srivastava A (2011) Hemophilia: disease, Diagnosis and Treatment. J Genet Syndr Gene Therapy 1:1–12CrossRefGoogle Scholar
  3. 3.
    Ota S, McLimont M, Carcao MD et al (2007) Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study. Haemophilia 13:12–20CrossRefPubMedGoogle Scholar
  4. 4.
    Roosendaal G, Lafeber F (2007) Prophylactic treatment for prevention of joint disease in hemophilia—cost versus benefit. N Engl J Med 357:603–605CrossRefPubMedGoogle Scholar
  5. 5.
    Van Dijk K, Fischer K, van der Bom JG, Grobbee DE, van den Berg HM (2005) Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed. Haemophilia 11(5):438–443CrossRefPubMedGoogle Scholar
  6. 6.
    Coppola A, Capua M (2010) Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med 1:183–195CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, Street A (2013) Guidelines for the management of Hemophilia. Hemophilia 19(1):1–47CrossRefGoogle Scholar
  8. 8.
    Pergantou H, Matsinos G, Platokouki H, Papadopoulos A, Aronis S (2009) An attempt to improve the clinical scale for assessment of haemophilic arthropathy in children. J Pediatr Orthop B 18:204–210CrossRefPubMedGoogle Scholar
  9. 9.
    Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D (2010) ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 8:2063–2065CrossRefPubMedGoogle Scholar
  10. 10.
    Payal V, Sharma P, Chhangani N, Janu Y, Singh Y, Sharma A (2015) Joint health status of hemophilia patients in Jodhpur region. Indian J Hematol Blood Transfus 31(3):362–366CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hayam M, Ghany A, Hassab H, El-Noueam K (2016) Hemophilic arthropathy: clinical, radiologic, and functional evaluation: a single-center experience in a limited resource country. Egypt Rheumatol Rehabil 43:35–40CrossRefGoogle Scholar
  12. 12.
    Abraham A, Apte S, Singh A, Subramanium K (2017) Meaningful reduction of annual bleeding rate with lower dose prophylaxis in minimally treated children with hemophilia in India. Blood 130:1079CrossRefGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2018

Authors and Affiliations

  1. 1.Department of PaediatricsMidnapore Medical CollegePaschim MedinipurIndia
  2. 2.KolkataIndia
  3. 3.Midnapore, Paschim MedinipurIndia

Personalised recommendations